Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

THE MAMMALIAN CELLULAR SPLICING MACHINE - STRUCTURE AND FUNCTION

Award Number: R01GM079549
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2008
PERIOD OF PERFORMANCE END DATE: 04/30/2012

Group Awards By:

View Award Description

THE MAMMALIAN CELLULAR SPLICING MACHINE - STRUCTURE AND FUNCTION - DESCRIPTION (provided by applicant): Most eukaryotic pre-mRNAs contain non-coding sequences (introns) that must be removed in order to accurately place the coding sequences (exons) in the correct reading frame. This critical regulatory event, termed pre-mRNA splicing, is fundamental in development and cancer, and occurs in a multi-component macromolecular machine, the spliceosome. Although the mechanism of pre-mRNA splicing has been extensively studied, the structure and regulation of this process is still not well understood. We have studied the mammalian splicing complex in its intact form, isolated from nuclei of living cells. The complexes we have isolated from cell nuclei are much larger than the splicing complexes assembled in vitro, and are thus termed supraspliceosomes. We have recently shown that the supraspliceosome is composed of four active native spliceosomes, each resembling the in vitro assembled spliceosome, which are connected via the pre-mRNA. Health Relevance: Defects in alternative splicing were correlated with human pathologies and malignancy. It is therefore anticipated that better understanding of the mechanism of pre-mRNA splicing should lead to better understanding of development and cancer. The long term objective of this project is to understand the regulation of splicing and alternative splicing, thus recognizing how defects in these important processes affect human diseases. Hypothesis: The isolated supraspliceosomes represent the steady-state population of nuclear pre-mRNAs that were isolated at different stages of the splicing reaction. It is thus assumed that developing methods for the preparation and isolation of homogeneous supraspliceosomes with respect to their transcript and splicing stage should allow us to get a higher resolution of the structure, a better knowledge of the components, localization and interactions within the supraspliceosome, and thus a better understanding of the working of the RNA splicing machine. Specific Aims: We propose to conduct in-depth structural and functional analyses of the native spliceosome and the supraspliceosome, including higher resolution structural analysis by the cryo-EM single particle techniques. We will perform analyses of native spliceosomes and supraspliceosomes assembled on specific transcripts, including alternatively spliced transcripts, and trapped in specific functional states (SA#1). We will also perform proteomic analyses by mass spectrometry of these complexes (SA#2). This approach might reveal differences in the composition of spliceosomes that were arrested at specific splicing stages or associated with different pre-mRNAs. Localization of spliceosomal components within supraspliceosomes and native spliceosomes derived from them will be performed using nucleic acids and antibodies tagged with gold-nanoclusters (SA#3), followed by cryo-EM structural analyses. The structural analyses will also include supraspliceosomes reconstituted with gold-tagged pre-mRNA. These experiments should assist in identifying the pre-mRNA pathway within the assembled complex and enable the localization of key spliceosomal components. PUBLIC HEALTH RELEVANCE: Defects in alternative splicing were correlated with human pathologies and malignancy. It is therefore anticipated that better understanding of the mechanism of pre-mRNA splicing should lead to better understanding of development and cancer. The long term objective of this project is to understand the regulation of splicing and alternative splicing, thus recognizing how defects in these important processes affect human diseases.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2011 ( Subtotal = $206,410 )
2011	2011	HEBREW UNIVERSITY	AUTHORITY FOR RESEARCH DEVELOPMENT	JERUSALEM				ISR	Biomedical Research and Research Training	000	5	4/13/2011	NON-COMPETING CONTINUATION	$187,645
2011	2011	HEBREW UNIVERSITY	AUTHORITY FOR RESEARCH DEVELOPMENT	JERUSALEM				ISR	Biomedical Research and Research Training	001	5	8/22/2011	NON-COMPETING CONTINUATION	$18,765
														Subtotal = $206,410

Issue Date FY: 2010 ( Subtotal = $208,494 )
2010	2010	HEBREW UNIVERSITY	AUTHORITY FOR RESEARCH DEVELOPMENT	JERUSALEM				ISR	Biomedical Research and Research Training	000	4	4/28/2010	NON-COMPETING CONTINUATION	$208,494
														Subtotal = $208,494

Issue Date FY: 2009 ( Subtotal = $210,600 )
2009	2009	HEBREW UNIVERSITY	AUTHORITY FOR RESEARCH DEVELOPMENT	JERUSALEM				ISR	Biomedical Research and Research Training	000	3	4/16/2009	NON-COMPETING CONTINUATION	$210,600
														Subtotal = $210,600

Issue Date FY: 2008 ( Subtotal = $210,600 )
2008	2008	YISSUM RESEARCH AND DEVELOPMENT CO	Hi-Tech Park, Edmond J. Safra Campus, Givat-Ram	JERUSALEM		91390		ISR	Biomedical Research and Research Training	000	1	4/18/2008	NEW	$0
2008	2008	HEBREW UNIVERSITY	**	JERUSALEM		00000		ISR	Biomedical Research and Research Training	000	2	5/12/2008	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$210,600
														Subtotal = $210,600

Grand Total All Awards = $836,104

Top

All Categories

About

Search

Reports

Data Submission

Award Information

THE MAMMALIAN CELLULAR SPLICING MACHINE - STRUCTURE AND FUNCTION

Award Number: R01GM079549

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2008

PERIOD OF PERFORMANCE END DATE: 04/30/2012

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer